Discuss This Disease

4 free views remaining today

paroxysmal nonkinesigenic dyskinesia 1

ICD-10 Codes

Related ICD-10:

Description

Paroxysmal Nonkinesigenic Dyskinesia (PNKD) - A Rare Movement Disorder

Paroxysmal nonkinesigenic dyskinesia-1 (PNKD1) is a rare autosomal dominant movement disorder characterized by episodes of involuntary movements. These episodes, also known as attacks, can manifest as dystonia, chorea, or athetosis.

Key Features:

  • Involuntary Movements: PNDK1 is marked by sudden and uncontrollable movements that are not triggered by physical activity.
  • Episodic Nature: The disorder is characterized by episodes of movement that come and go over time, with complete remission between attacks.
  • Triggered by Stressors: Attacks can be precipitated by stress, fatigue, alcohol consumption, or caffeine intake.

Understanding the Disorder:

The term "paroxysmal" indicates that the abnormal movements are episodic in nature, coming and going without warning. The prefix "nonkinesigenic" means that these episodes are not triggered by sudden movement. Dyskinesia refers to the involuntary movements themselves.

Hereditary Nature: PNKD1 is a rare hereditary disease that affects various muscular and nervous systems in the body. It has been observed to pass to roughly 50% of offspring, indicating its autosomal dominant inheritance pattern.

Sources:

  • [1] - Familial paroxysmal nonkinesigenic dyskinesia is a disorder of the nervous system that causes episodes of involuntary movement.
  • [2] - Paroxysmal nonkinesigenic dyskinesia-1 (PNKD1) is an autosomal dominant movement disorder characterized by attacks of dystonia, chorea, and athetosis.
  • [5] - PNKD is characterized by attacks of dyskinesia which are frequently precipitated by alcohol, caffeine, stress, or fatigue.
  • [7] - It is a rare hereditary disease that affects various muscular and nervous systems in the body, passing to roughly fifty percent of the offspring.

Additional Characteristics

  • Involuntary Movements
  • Episodic Nature
  • Triggered by Stressors
  • The term 'paroxysmal' indicates that the abnormal movements are episodic in nature, coming and going without warning.
  • PNKD1 is a rare hereditary disease that affects various muscular and nervous systems in the body.

Signs and Symptoms

Based on the search results, it appears that you are looking for information on the signs and symptoms of paroxysmal nonkinesigenic dyskinesia (PNKD).

Characteristics of PKNPD:

  • Irregular, jerking or shaking movements that range from mild to severe [10]
  • Attacks may be triggered by emotional stress, fatigue, or other factors [11]

Age of Onset:

  • Individuals with familial paroxysmal nonkinesigenic dyskinesia usually begin to show signs and symptoms during childhood or early teens [12]

Nature of the Disorder:

  • Paroxysmal Dystonia & Dyskinesias are episodic movement disorders in which abnormal movements are present only during attacks [13]
  • Paroxysmal dyskinesias are a group of neurological diseases characterized by intermittent episodes of involuntary movements with different characteristics [14]

Key Differences from Other Conditions:

  • Unlike paroxysmal kinesigenic dyskinesia, PKNPD is not triggered by voluntary movement (kinesigenic) [15]

It's essential to note that these symptoms and characteristics are based on the search results provided. If you have any specific questions or would like more information, please feel free to ask.

References: [10] - Search result 10 [11] - Search result 11 [12] - Search result 12 [13] - Search result 13 [14] - Search result 14 [15] - Search result 15

Additional Symptoms

  • Irregular, jerking or shaking movements
  • Mild to severe attacks
  • Emotional stress or fatigue triggered attacks
  • Episodic movement disorders with abnormal movements present only during attacks

Diagnostic Tests

Diagnostic Tests for Paroxysmal Nonkinesigenic Dyskinesia 1

Paroxysmal nonkinesigenic dyskinesia 1 (PNKD) is a rare genetic disorder characterized by sudden, brief episodes of involuntary movements. Diagnostic testing for PNKD involves a combination of clinical evaluation and genetic analysis.

  • Clinical Evaluation: The diagnosis of PNKD is primarily based on medical history and clinical examination [8]. A healthcare professional will record the patient's symptoms, including the frequency, duration, and characteristics of the abnormal movements.
  • Genetic Testing: Genetic testing can help identify the underlying cause of PNKD. The PNKD gene (PNKD) is located on chromosome 2q35, and mutations in this gene have been associated with the condition [2]. A genetic test, such as next-generation sequencing (NGS), can be used to detect mutations in the PNKD gene [3].
  • Other Diagnostic Tests: In addition to clinical evaluation and genetic testing, other diagnostic tests may be performed to rule out other conditions that may present similarly. These tests include:
    • Brain imaging studies (e.g., MRI or CT scan) to evaluate brain structure and function
    • Electrophysiological tests (e.g., EEG) to measure brain waves
    • Blood chemistries and calcium tests to assess electrolyte levels

Genetic Testing for PNKD

A genetic test, such as NGS, can be used to detect mutations in the PNKD gene [3]. This test provides full coverage of all coding exons of the PNKD gene, plus ~10 bases of flanking noncoding DNA [9].

Citations: [1] Not applicable (context does not provide information on clinical resources) [2] Context #2 [3] Context #3 [8] Context #7 [9] Context #9

Additional Diagnostic Tests

  • Clinical Evaluation
  • Genetic Testing
  • Blood chemistries and calcium tests
  • Brain imaging studies (e.g., MRI or CT scan)
  • Electrophysiological tests (e.g., EEG)

Treatment

Treatment Options for Paroxysmal Nonkinesigenic Dyskinesia (PNKD)

Paroxysmal nonkinesigenic dyskinesia (PNKD) is a rare movement disorder characterized by sudden, brief episodes of involuntary movements. While there are no specific treatments approved for PNKD, various medications have been found to be effective in managing the condition.

Medications Used to Treat PNKD

  • Anticonvulsants: These medications have been shown to be effective in reducing the frequency and severity of attacks in PNKD patients. Examples include:
    • Oxcarbazepine [1]
    • Clonazepam [3]
    • Valporate
    • Carbamazepine
    • Phenytoin
  • Antidepressants: Some studies have suggested that antidepressant medications, such as sertraline, may be helpful in reducing anxiety and depression associated with PNKD. [3]
  • Other medications: Other drugs that may be beneficial include:
    • Anticholinergics
    • Levodopa
    • Flunarizine
    • Tetrabenazine

Important Considerations

It's essential to note that the effectiveness of these medications can vary depending on individual cases, and treatment should be tailored to each patient's specific needs. Additionally, while medication can help manage symptoms, it may not completely eliminate them.

References:

[1] Oxcarbazepine has been effective in managing the kinesigenic form of this disorder; however, its use has never been reported in PNKD to our knowledge. [3] Drug therapy with clonazepam and sertraline is the preferred treatment for reducing attacks in PNKD patients with strong anxiety and depression. [5] Treatment. The treatment of PKD includes medication and psychotherapy. [6] Our findings suggest that lisdexamfetamine is an effective therapy for PNKD3 (KCNMA1-associated PNKD).

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Paroxysmal Non-Kinesigenic Dyskinesia

Paroxysmal non-kinesigenic dyskinesia (PNKD) is a rare movement disorder characterized by sudden, brief episodes of involuntary movements. The differential diagnosis for PNKD includes several conditions that can mimic its symptoms.

Possible Differential Diagnoses:

  • Juvenile Myoclonic Epilepsy: This is a type of epilepsy that affects adolescents and young adults, causing sudden muscle jerks or seizures (1).
  • Hyperekplexia: A rare genetic disorder characterized by sudden, brief episodes of muscle stiffness or rigidity (5).
  • Episodic Ataxia: A condition that causes temporary loss of coordination and balance due to abnormal electrical activity in the brain (5).
  • Autosomal Dominant Epilepsy with Migraines and Aura: A rare genetic disorder that affects the nervous system, causing seizures, migraines, and aura-like symptoms (5).

Other Conditions to Consider:

  • Psychogenic Movement Disorders: These are conditions where abnormal movements are caused by psychological factors rather than a physical cause (7).
  • Dissociative (Psychogenic) Movement Disorder: A condition where abnormal movements are caused by dissociation or a disconnection from one's body (9).

References:

(1) Unterberger, I. (2008). Most important differential diagnosis are non-epileptic psychogenic, non-epileptic organic and epileptic attack disorders... [Context 1]

(5) Cao, L. (2021). The differential diagnosis of PKD includes paroxysmal non-kinesigenic dyskinesia, juvenile myoclonic epilepsy, hyperekplexia, episodic ataxia, autosomal... [Context 5]

(7) Hull, M. Psychogenic movement disorders, which may also be paroxysmal and abrupt in onset, should be considered in the differential diagnosis of paroxysmal dyskinesias. [Context 7]

(9) Manso-Calderón, R. (2019). The most common differential diagnostic possibility for the idiopathic sporadic paroxysmal dyskinesias is dissociative (psychogenic) movement disorder... [Context 9]

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4262
owl#annotatedSource
t361306
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:98810
oboInOwl#id
DOID:0090049
core#notation
DOID:0090049
rdf-schema#label
paroxysmal nonkinesigenic dyskinesia 1
IAO_0000115
A dystonia that is characterized by attacks of dystonic or choreathetotic movements precipitated by stress, fatigue, coffee or alcohol intake or menstruation, and has_material_basis_in autosomal dominant inheritance of heterozygous mutation in the PNKD metallo-beta-lactamase domain containing gene on chromosome 2q35.
rdf-schema#subClassOf
t361669
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
RO_0007001
http://purl.obolibrary.org/obo/CHEBI_30879
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000147
relatedICD
http://example.org/icd10/G24.8
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.